CBUS CIK: 1705843

Cibus, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
15.2
FY22:
4.13
FY23:
35.2
FY24:
16.9
FY25:
12.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
22.0
FY22:
18.3
FY23:
509
FY24:
333
FY25:
293
Total assets
Change from FY21 to FY25
millions USD
FY21:
37.2
FY22:
22.4
FY23:
544
FY24:
350
FY25:
305

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
4.85
FY22:
1.66
FY23:
21.3
FY24:
19.9
FY25:
16.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
18.2
FY22:
13.5
FY23:
185
FY24:
232
FY25:
266
(positive)
Change from FY21 to FY25
millions USD
FY21:
14.1
FY22:
7.23
FY23:
293
FY24:
92.2
FY25:
21.8
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
37.2
FY22:
22.4
FY23:
–
FY24:
–
FY25:
305

All amounts in millions USD Data source:SEC EDGAR